Clinical Trial Update: Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating bortezomib in combination with chemotherapy for relapsed pediatric acute lymphoblastic leukemia; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-19